Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model
暂无分享,去创建一个
Nora C. Bridges | D. Kelley | J. Pringle | A. Gordon | J. Donohue | Gerald T. Cochran | T. Bear | Evan Cole | J. Kmiec | Abigail L. Foulds | Ellen DiDomenico | R. Taber | J. P. Miller | Renee M Cloutier | Brianna L. McDonough | Daniel A. Lomauro | A. Talbert | Rachel Taber | Dale Adair | Evan S Cole | Renee M. Cloutier
[1] Nate C. Apathy,et al. Evaluation of electronic recruitment efforts of primary care providers as research subjects during the COVID-19 pandemic , 2022, BMC Primary Care.
[2] D. Jonas,et al. Barriers to recruiting primary care practices for implementation research during COVID-19: A qualitative study of practice coaches from the Stop Unhealthy (STUN) Alcohol Use Now trial , 2022, Implementation research and practice.
[3] Nora C. Bridges,et al. Medications for Opioid Use Disorder in Rural Primary Care Practices: Patient and Provider Experiences , 2022, SSRN Electronic Journal.
[4] K. Zivin,et al. Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018. , 2021, JAMA.
[5] Sally A. Kraft,et al. Multidisciplinary Treatment of Opioid Use Disorder in Primary Care Using the Collaborative Care Model , 2021, Substance abuse.
[6] D. Kelley,et al. Provider and Patient-panel Characteristics Associated With Initial Adoption and Sustained Prescribing of Medication for Opioid Use Disorder , 2021, Journal of addiction medicine.
[7] P. Nourjah,et al. “One size does not fit all” and other lessons learned from grants for implementation of the AHRQ medication assisted treatment for opioid use disorder in rural primary care , 2021, Substance abuse.
[8] J. Westfall,et al. The who, the what, and the how: A description of strategies and lessons learned to expand access to medications for opioid use disorder in rural America , 2021, Substance abuse.
[9] James H. Ford,et al. Improving medication access within integrated treatment for individuals with co-occurring disorders in substance use treatment agencies , 2021, Implementation research and practice.
[10] Kayne D. Mettert,et al. Transitioning patients from outpatient mental health services to primary care: A rapid literature review , 2021, Implementation research and practice.
[11] Cheri J. Shapiro,et al. Provider self-efficacy in delivering evidence-based psychosocial interventions: A scoping review , 2021, Implementation research and practice.
[12] M. Farkas,et al. Ready to roll: Strategies and actions to enhance organizational readiness for implementation in community mental health , 2021, Implementation research and practice.
[13] Kayne D. Mettert,et al. Determining the influence of intervention characteristics on implementation success requires reliable and valid measures: Results from a systematic review , 2021, Implementation research and practice.
[14] Audrey L. Jones,et al. Aims, development, and early results of an interdisciplinary primary care initiative to address patient vulnerabilities , 2020, The American journal of drug and alcohol abuse.
[15] A. Dopp,et al. Combatting the Stigma of Addiction - The Need for a Comprehensive Health System Approach. , 2020, NAM perspectives.
[16] Christopher M. Jones,et al. The American Opioid Epidemic in Special Populations: Five Examples. , 2020, NAM perspectives.
[17] E. Hawkins,et al. Article Commentary: Stepped Care for Opioid Use Disorder Train the Trainer (Scoutt) Initiative: Expanding Access to Medication Treatment for Opioid Use Disorder within Veterans Health Administration Facilities , 2020, Substance abuse.
[18] B. Madras,et al. Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System. , 2020, NAM perspectives.
[19] T. Wiegand,et al. The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update. , 2020, Journal of addiction medicine.
[20] David K. Wyant,et al. Compositional and contextual factors associated with drug overdose deaths in the United States , 2020, Journal of addictive diseases.
[21] Julie A. Jackson,et al. Understanding Barriers and Facilitators to the Uptake of Best Practices for the Treatment of Co-Occurring Chronic Pain and Opioid Use Disorder , 2019, Journal of dual diagnosis.
[22] Robin Ghertner. U.S. trends in the supply of providers with a waiver to prescribe buprenorphine for opioid use disorder in 2016 and 2018. , 2019, Drug and alcohol dependence.
[23] M. Schechter,et al. Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review , 2019, Substance Abuse Treatment, Prevention, and Policy.
[24] S. Friedman,et al. Social norms associated with nonmedical opioid use in rural communities: a systematic review. , 2019, Translational behavioral medicine.
[25] K. Peterson,et al. Evidence Brief: Barriers and Facilitators to Use of Medications for Opioid Use Disorder , 2019 .
[26] D. Kelley,et al. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers , 2019, Addiction Science & Clinical Practice.
[27] Christopher M. Jones,et al. Co-occurring substance use and mental disorders among adults with opioid use disorder. , 2019, Drug and alcohol dependence.
[28] R. Rahman,et al. Nurturing Practitioner-Researcher Partnerships to Improve Adoption and Delivery of Research-Based Social and Public Health Services Worldwide , 2019, International journal of environmental research and public health.
[29] S. Weiner,et al. Stewarding Recovery from the Opioid Crisis Through Health System Initiatives , 2019, The western journal of emergency medicine.
[30] R. Kullar,et al. The association between perceived stigma and substance use disorder treatment outcomes: a review , 2018, Substance abuse and rehabilitation.
[31] A. Leshner,et al. Medications for Opioid Use Disorder Save Lives , 2019 .
[32] D. Patterson,et al. Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine. , 2018, American journal of preventive medicine.
[33] A. Bohnert,et al. Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment. , 2018, American journal of preventive medicine.
[34] Mindy E. Flanagan,et al. Inside help: An integrative review of champions in healthcare-related implementation , 2018, SAGE open medicine.
[35] Benjamin P Linas,et al. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. , 2018, Journal of substance abuse treatment.
[36] Kathy A Scott,et al. The Power of the Frame: Systems Transformation Framework for Health Care Leaders , 2018, Nursing administration quarterly.
[37] Christopher M. Jones,et al. Nonmedical Prescription Opioid Use and Use Disorders Among Adults Aged 18 Through 64 Years in the United States, 2003-2013. , 2015, JAMA.
[38] L. A. Kazal,et al. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians. , 2015, Rural and remote health.
[39] E. Brouwers,et al. [Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review]. , 2015, Tijdschrift voor psychiatrie.
[40] Thomas R Frieden,et al. Medication-assisted therapies--tackling the opioid-overdose epidemic. , 2014, The New England journal of medicine.
[41] R. Rosenblatt,et al. Barriers to Primary Care Physicians Prescribing Buprenorphine , 2014, The Annals of Family Medicine.
[42] Udi E. Ghitza,et al. Can Substance Use Disorders be Managed Using the Chronic Care Model? Review and Recommendations from a NIDA Consensus Group , 2013, Public Health Reviews.
[43] P. Skorga,et al. Collaborative care for depression and anxiety problems , 2013 .
[44] Sandra E. Larios,et al. Confidentiality protections versus collaborative care in the treatment of substance use disorders , 2013, Addiction Science & Clinical Practice.
[45] Mark T Hegel,et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. , 2002, JAMA.
[46] A T McLellan,et al. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. , 2000, JAMA.
[47] J. Wall. Collaborative Care. , 1993, Virginia dental journal.
[48] Daniel Roos,et al. The machine that changed the world : the story of lean production , 1991 .
[49] 元木 良一,et al. Drug Overdose , 1972, Southern medical journal.